In a patient with suspected chronic pancreatitis, should a contrast‑enhanced abdominal CT be used as the initial diagnostic imaging study?

CT Abdomen for Diagnosis of Chronic Pancreatitis

Contrast-enhanced CT is an appropriate and often the most practical initial imaging modality for suspected chronic pancreatitis, though it cannot exclude early or mild disease. 1, 2

Diagnostic Performance and Role

CT serves as a reasonable first-line imaging study for chronic pancreatitis evaluation, particularly when:

• Excluding other pathology: CT effectively rules out alternative intraabdominal conditions that may present with similar symptoms 2
• Detecting advanced disease: CT excels at identifying established morphologic changes including calcifications, ductal dilation, atrophy, and parenchymal changes 1, 2
• Assessing calcification patterns: The addition of non-contrast imaging helps characterize calcifications—chronic pancreatitis typically shows diffuse and intraductal calcifications 3

Diagnostic Accuracy

A meta-analysis demonstrates CT has 75% sensitivity (95% CI: 66%-83%) and 91% specificity (95% CI: 81%-96%) for chronic pancreatitis diagnosis 4. This performance is comparable to MRI (78% sensitivity, 96% specificity) and EUS (81% sensitivity, 90% specificity) 4.

Critical Limitations

CT cannot exclude chronic pancreatitis and should not be used to exclusively diagnose early or mild disease 2. This is a crucial pitfall—a negative or equivocal CT in a patient with high clinical suspicion requires further evaluation.

Recommended Imaging Algorithm

When chronic pancreatitis is suspected:

1. Initial imaging: Contrast-enhanced CT (pancreatic protocol with late arterial and portal venous phases) 1, 2

2. If CT is negative or equivocal but clinical suspicion persists:

   • MRI/MRCP is superior for detecting early disease and subtle ductal changes 2, 5
   • Secretin-stimulated MRCP should be performed after negative standard MRCP when suspicion remains high 2
   • EUS can detect parenchymal and ductal changes in early-stage disease 2, 4

3. Optimal modality selection: EUS and ERCP are "outperformers" with the highest diagnostic accuracy, while ultrasound has the lowest 4

Technical Specifications

When CT is performed, use:

• Dual-phase pancreatic protocol (late arterial and portal venous phases with multiplanar reformations) 6
• Intravenous contrast to improve detection of parenchymal changes and complications 6
• Non-contrast phase specifically to assess calcification patterns 3

Common Pitfalls to Avoid

• Do not rely on CT alone to rule out chronic pancreatitis—sensitivity decreases significantly in early disease 2
• Do not skip advanced imaging (MRI/MRCP or EUS) when CT is inconclusive but clinical suspicion is high 2, 7
• Do not confuse focal pancreatitis with pancreatic cancer—this requires MRI or EUS for differentiation 5

The choice between imaging modalities after an inconclusive CT should be based on local expertise, availability, and the specific clinical question, with MRI/MRCP and EUS being complementary rather than competitive 2, 4, 7.